U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C12H8O4
Molecular Weight 216.1895
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BERGAPTEN

SMILES

COC1=C2C=COC2=CC3=C1C=CC(=O)O3

InChI

InChIKey=BGEBZHIAGXMEMV-UHFFFAOYSA-N
InChI=1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3

HIDE SMILES / InChI
Bergapten, known as 5-methoxypsoralen, a cumarine-derivate compound, presents in many fruits and vegetables. It has shown antitumor effects in a variety of cell types. The key target of bergapten action in breast cancer cells was identified the oncosuppressor gene PTEN (phosphatase tensin homolog deleted from chromosome 10); bergapten by inducing PTEN expression, produces autophagy in breast cancer cells. Besides, bergapten is under investigation in clinical trial phase III for patients with severe generalized atopic dermatitis.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Geralen

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
82 ng/mL
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
89 ng/mL
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
175 ng/mL
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
108 μg/L
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
322 μg/L
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1754 ng × h/mL
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
1757 ng × h/mL
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
3282 ng × h/mL
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
276 μg × h/L
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
942 μg × h/L
1.2 mg/kg single, oral
dose: 1.2 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
BERGAPTEN serum
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FED
Doses

Doses

DosePopulationAdverse events​
1.2 mg/kg 1 times / day multiple, oral
Studied dose
Dose: 1.2 mg/kg, 1 times / day
Route: oral
Route: multiple
Dose: 1.2 mg/kg, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
Other AEs: Vomiting...
Other AEs:
Vomiting (4%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Vomiting 4%
1.2 mg/kg 1 times / day multiple, oral
Studied dose
Dose: 1.2 mg/kg, 1 times / day
Route: oral
Route: multiple
Dose: 1.2 mg/kg, 1 times / day
Sources:
unhealthy, ADULT
Health Status: unhealthy
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
The psoralens adversely affect reproductive function in male wistar rats.
2001 Mar-Apr
Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.
2001 Sep-Dec
Chalcones and other constituents of Dorstenia prorepens and Dorstenia zenkeri.
2002 Apr
Effects of storage conditions on furocoumarin levels in intact, chopped, or homogenized parsnips.
2002 Apr 24
Constituents of the fruits and leaves of Euodia daniellii.
2002 Dec
Bullous phytophotodermatitis associated with high natural concentrations of furanocoumarins in limes.
2002 Mar
Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.
2002 Nov 15
Determination of 5-methoxypsoralen in human serum.
2002 Oct 15
Tea: not immoral, illegal, or fattening, but is it innocuous?
2002 Sep 14
In vivo effect of 5- and 8-methoxypsoralens and cimetidine on R,S-warfarin metabolism in rat.
2002 Sep-Oct
Effect of psoralens on Fenton-like reaction generating reactive oxygen species.
2003
Assessing the separation of neutral plant secondary metabolites by micellar electrokinetic chromatography.
2003 Jul 4
Antibacterial coumarins from Angelica gigas roots.
2003 Jun
Effect of 5-methoxypsoralen (5-MOP) on cell apoptosis and cell cycle in human hepatocellular carcinoma cell line.
2003 Jun
Coumarins from Cnidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells.
2004 Aug
Preparative isolation and purification of bergapten and imperatorin from the medicinal plant Cnidium monnieri using high-speed counter-current chromatography by stepwise increasing the flow-rate of the mobile phase.
2004 Dec 17
Prenylated flavonoids, monoterpenoid furanocoumarins and other constituents from the twigs of Dorstenia elliptica (Moraceae).
2004 Jan
Furanocoumarin biosynthesis in Ammi majus L. Cloning of bergaptol O-methyltransferase.
2004 Mar
Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research.
2004 Sep
Accumulation of biologically active furanocoumarins in agitated cultures of Ruta graveolens L. and Ruta graveolens ssp. divaricata (Tenore) Gams.
2005 Aug
Accumulation of biologically active furanocoumarins in Ruta graveolens ssp. divaricata (Tenore) Gams in vitro culture.
2005 Jan
Internet-based search of randomised trials relevant to mental health originating in the Arab world.
2005 Jul 26
Post-stress metabolism involves umbelliferone production in anthocyanin-producing and nonproducing cells of Glehnia littoralis suspension cultures.
2005 Jun
Two new sesquiterpenoids and anti-HIV principles from the root bark of Zanthoxylum ailanthoides.
2005 Nov 1
Effects of 5-methoxypsoralen (5-MOP) on arylamine N-acetyltransferase activity in the stomach and colon of rats and human stomach and colon tumor cell lines.
2005 Nov-Dec
Remarkable substrate-specificity of CYP6AB3 in Depressaria pastinacella, a highly specialized caterpillar.
2006 Apr
A method for quantitative determination of furanocoumarins in capsules and tablets of phytochemical preparations.
2006 Apr
[Studies on chemical constituents from roots of Peucedanum praeruptorum II].
2006 Aug
[Studies on chemical constituents in roots of Heracleum rapula].
2006 Feb
Cytochrome P450-mediated metabolism of xanthotoxin by Papilio multicaudatus.
2006 Mar
Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
2006 Mar
Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
2006 Sep
Use of the yeast Saccharomyces cerevisiae as a pre-screening approach for assessment of chemical-induced phototoxicity.
2006 Sep
Inhibition on human liver cytochrome P450 3A4 by constituents of fennel (Foeniculum vulgare): identification and characterization of a mechanism-based inactivator.
2007 Dec 12
Ethnoveterinary medicines used for ruminants in British Columbia, Canada.
2007 Feb 26
Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.
2007 Jul
Quality assessment of Rhizoma et Radix Notopterygii by HPTLC and HPLC fingerprinting and HPLC quantitative analysis.
2007 Jul 27
Herbal medicine today: clinical and research issues.
2007 Sep
[Simultaneous determination of 8-methoxypsoralen and 5-methoxypsoralen in cosmetics using LC-MS/MS].
2007 Sep
[Simultaneous determination of 5 active components in Fructus Cnidii by HPLC].
2007 Sep
Coumarins from Peucedanum luxurians.
2007 Sep
Central role of mitochondria and p53 in PUVA-induced apoptosis in human keratinocytes cell line NCTC-2544.
2008 Feb 15
Induction of gamma-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives.
2008 Feb 15
In vivo methods for the assessment of topical drug bioavailability.
2008 Jan
Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
2008 Jan 28
Irritant and cytotoxic coumarins from Angelica glauca Edgew roots.
2008 Jan-Feb
Identification of Ruta graveolens L. metabolites accumulated in the presence of abiotic elicitors.
2008 Jan-Feb
Effective biotic elicitation of Ruta graveolens L. shoot cultures by lysates from Pectobacterium atrosepticum and Bacillus sp.
2008 Mar
In vitro antiplasmodial activity of extract and constituents from Esenbeckia febrifuga, a plant traditionally used to treat malaria in the Brazilian Amazon.
2008 May
Application of chitin and chitosan as elicitors of coumarins and fluoroquinolone alkaloids in Ruta graveolens L. (common rue).
2008 Oct
Patents

Sample Use Guides

1,2 mg/kg 2 hours before UVA irradiation p.o. 3 times weekly for 5 weeks
Route of Administration: Oral
Bone marrow stromal cells (BMSCs) were cultured in osteogenic induction medium with the addition of bergapten for 2 weeks. The concentrations of bergapten used were 0.1, 1, and 10 μmol/L in vitro. Bergapten promotes the expression of alkaline phosphatase (ALP) by BMSCs in vitro in a dose-dependent manner, as revealed by ALP staining.
Name Type Language
5-METHOXYPSORALEN
MART.   WHO-DD  
Preferred Name English
BERGAPTEN
MI  
Common Name English
5-METHOXYPSORALEN [IARC]
Common Name English
4-METHOXY-7H-FURO(3,2-G)(1)BENZOPYRAN-7-ONE
Systematic Name English
BERGAPTEN [MI]
Common Name English
METHOXSALEN RELATED COMPOUND A [USP-RS]
Common Name English
GERALEN
Common Name English
METHOXSALEN RELATED COMPOUND A [USP IMPURITY]
Common Name English
5-METHOXYPSORALEN [MART.]
Common Name English
BERGAPTENE
Common Name English
MAJUDIN
Common Name English
NSC-95437
Code English
BERGAPTAN
Common Name English
HERACLIN
Common Name English
5-methoxypsoralen [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC D05BA03
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
WHO-VATC QD05BA03
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL24171
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
HSDB
3466
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
FDA UNII
4FVK84C92X
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
DRUG BANK
DB12216
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
CHEBI
18293
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-604-5
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
CAS
484-20-8
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
PUBCHEM
2355
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
NSC
95437
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
RXCUI
15842
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY RxNorm
MESH
C022909
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
RS_ITEM_NUM
1065345
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
SMS_ID
100000078282
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
DRUG CENTRAL
3021
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
EPA CompTox
DTXSID1025560
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
EVMPD
SUB12695MIG
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY
MERCK INDEX
m2430
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
BERGAPTEN
Created by admin on Mon Mar 31 18:12:33 GMT 2025 , Edited by admin on Mon Mar 31 18:12:33 GMT 2025
PRIMARY